Corcept Therapeutics, Inc. (CORT)
113.34
-0.54
(-0.47%)
USD |
NASDAQ |
Aug 31, 16:00
113.34
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Cash from Operations (Annual) : 142.00M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 142.00M |
| December 31, 2024 | 198.30M |
| December 31, 2023 | 127.04M |
| December 31, 2022 | 120.32M |
| December 31, 2021 | 167.89M |
| December 31, 2020 | 151.97M |
| December 31, 2019 | 136.12M |
| December 31, 2018 | 115.66M |
| December 31, 2017 | 60.94M |
| December 31, 2016 | 18.39M |
| December 31, 2015 | 3.13M |
| December 31, 2014 | -27.38M |
| Date | Value |
|---|---|
| December 31, 2013 | -37.06M |
| December 31, 2012 | -36.02M |
| December 31, 2011 | -27.40M |
| December 31, 2010 | -22.28M |
| December 31, 2009 | -17.97M |
| December 31, 2008 | -18.36M |
| December 31, 2007 | -10.96M |
| December 31, 2006 | -23.24M |
| December 31, 2005 | -17.23M |
| December 31, 2004 | -13.72M |
| December 31, 2003 | -10.00M |
| December 31, 2002 | -13.23M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Liquidia Corp. | -35.69M |
| Eli Lilly & Co. | 16.81B |
| Abeona Therapeutics, Inc. | -76.33M |
| Indivior Pharmaceuticals, Inc. | -27.00M |
| Crinetics Pharmaceuticals, Inc. | -377.92M |